Gupta, A., Thompson, D., Whitehouse, A., Collier, T., Dahlof, B., Poulter, N., . . . Sever, P. (2017). Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): A randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. The Lancet (British edition), 389(10088), 2473-2481. https://doi.org/10.1016/S0140-6736(17)31075-9
Citace podle Chicago (17th ed.)Gupta, Ajay, David Thompson, Andrew Whitehouse, Tim Collier, Bjorn Dahlof, Neil Poulter, Rory Collins, a Peter Sever. "Adverse Events Associated with Unblinded, but Not with Blinded, Statin Therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): A Randomised Double-blind Placebo-controlled Trial and Its Non-randomised Non-blind Extension Phase." The Lancet (British Edition) 389, no. 10088 (2017): 2473-2481. https://doi.org/10.1016/S0140-6736(17)31075-9.
Citace podle MLA (9th ed.)Gupta, Ajay, et al. "Adverse Events Associated with Unblinded, but Not with Blinded, Statin Therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): A Randomised Double-blind Placebo-controlled Trial and Its Non-randomised Non-blind Extension Phase." The Lancet (British Edition), vol. 389, no. 10088, 2017, pp. 2473-2481, https://doi.org/10.1016/S0140-6736(17)31075-9.